Literature DB >> 21237263

LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent.

Shweta S Puntambekar1, Deirdre S Davis, Leo Hawel, Janelle Crane, Craig V Byus, Monica J Carson.   

Abstract

Increased polyamine production is observed in a variety of chronic neuroinflammatory disorders, but in vitro and in vivo studies yield conflicting data on the immunomodulatory consequences of their production. Ornithine decarboxylase (ODC) is the rate-limiting enzyme in endogenous polyamine production. To identify the role of polyamine production in CNS-intrinsic inflammatory responses, we defined CNS sites of ODC expression and the consequences of inhibiting ODC in response to intracerebral injection of LPS±IFNγ. In situ hybridization analysis revealed that both neurons and non-neuronal cells rapidly respond to LPS±IFNγ by increasing ODC expression. Inhibiting ODC by co-injecting DFMO decreased LPS-induced CCL2 expression and macrophage influx into the CNS, without altering LPS-induced microglial or macrophage activation. Conversely, intracerebral injection of polyamines was sufficient to trigger macrophage influx into the CNS of wild-type but not CCL2KO mice, demonstrating the dependence of macrophage influx on CNS expression of CCL2. Consistent with these data, addition of putrescine and spermine to mixed glial cultures dramatically increased CCL2 expression and to a much lesser extent, TNF expression. Addition of all three polyamines to mixed glial cultures also decreased the numbers and percentages of oligodendrocytes present. However, in vivo, inhibiting the basal levels of polyamine production was sufficient to induce expression of apolipoprotein D, a marker of oxidative stress, within white matter tracts. Considered together, our data indicate that: (1) CNS-resident cells including neurons play active roles in recruiting pro-inflammatory TREM1-positive macrophages into the CNS via polyamine-dependent induction of CCL2 expression and (2) modulating polyamine production in vivo may be a difficult strategy to limit inflammation and promote repair due to the dual homeostatic and pro-inflammatory roles played by polyamines.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237263      PMCID: PMC3081407          DOI: 10.1016/j.bbi.2010.12.016

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  49 in total

1.  Structural stabilization of CNS synapses during postnatal development in rat cortex.

Authors:  Zin Z Khaing; Lazar Fidler; Nina Nandy; Greg R Phillips
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

Review 2.  Mammalian polyamine metabolism and function.

Authors:  Anthony E Pegg
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

Review 3.  A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease.

Authors:  Monica J Carson; Tina V Bilousova; Shweta S Puntambekar; Benoit Melchior; Jonathan M Doose; Iryna M Ethell
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

4.  Mature microglia resemble immature antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Glia       Date:  1998-01       Impact factor: 7.452

Review 5.  Interactions of polyamines with ion channels.

Authors:  K Williams
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  Polyamines modulate events mediated by the N-methyl-D-aspartate (NMDA) receptor complex through an ifenprodil-insensitive pathway: in vivo measurements of cyclic GMP in the cerebellum.

Authors:  T S Rao; J A Cler; S J Mick; S Iyengar; P L Wood
Journal:  Neuropharmacology       Date:  1991-06       Impact factor: 5.250

7.  Brain polyamine levels are altered in Alzheimer's disease.

Authors:  L D Morrison; S J Kish
Journal:  Neurosci Lett       Date:  1995-09-01       Impact factor: 3.046

8.  Regulation of putrescine export in lipopolysaccharide or IFN-gamma-activated murine monocytic-leukemic RAW 264 cells.

Authors:  R R Tjandrawinata; L Hawel; C V Byus
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

9.  Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo.

Authors:  Ying Gao; Kangwen Deng; Jianwei Hou; J Barney Bryson; Angel Barco; Elena Nikulina; Tim Spencer; Wilfredo Mellado; Eric R Kandel; Marie T Filbin
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

10.  Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.

Authors:  Christoph D Schmid; Benoit Melchior; Kokoechat Masek; Shweta S Puntambekar; Patria E Danielson; David D Lo; J Gregor Sutcliffe; Monica J Carson
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

View more
  14 in total

1.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

2.  Maltotriose Conjugated Metal-Organic Frameworks for Selective Targeting and Photodynamic Therapy of Triple Negative Breast Cancer Cells and Tumor Associated Macrophages.

Authors:  Yoshie Sakamaki; John Ozdemir; Alda Diaz Perez; Zachary Heidrick; Olivia Watson; Miu Tsuji; Chirstopher Salmon; Joseph Batta-Mpouma; Anthony Azzun; Valerie Lomonte; Yuchun Du; Julie Stenken; Jin Woo-Kim; M Hassan Beyzavi
Journal:  Adv Ther (Weinh)       Date:  2020-06-08

3.  IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury.

Authors:  Ashley M Fenn; Jodie C E Hall; John C Gensel; Phillip G Popovich; Jonathan P Godbout
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

Review 4.  Polyamines in aging and disease.

Authors:  Nadège Minois; Didac Carmona-Gutierrez; Frank Madeo
Journal:  Aging (Albany NY)       Date:  2011-08       Impact factor: 5.682

5.  Spermine reverses lipopolysaccharide-induced memory deficit in mice.

Authors:  Pâmella Karina Santana Frühauf; Rafael Porto Ineu; Lediane Tomazi; Thiago Duarte; Carlos Fernando Mello; Maribel Antonello Rubin
Journal:  J Neuroinflammation       Date:  2015-01-09       Impact factor: 8.322

6.  CCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous System.

Authors:  Benjamin D Clarkson; Alec Walker; Melissa G Harris; Aditya Rayasam; Martin Hsu; Matyas Sandor; Zsuzsanna Fabry
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

7.  Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Authors:  Kyung-Ran Park; Chul Ju Hwang; Hyung-Mun Yun; In Jun Yeo; Dong-Young Choi; Pil-Hoon Park; Hyung Sook Kim; Jung Tae Lee; Young Suk Jung; Sang-Bae Han; Jin Tae Hong
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832

8.  Comparative study of the effect of LPS on the function of BALB/c and C57BL/6 peritoneal macrophages.

Authors:  Sara Soudi; Ahmad Zavaran-Hosseini; Zuhair Muhammad Hassan; Masoud Soleimani; Fatemeh Jamshidi Adegani; Seyed Mahmoud Hashemi
Journal:  Cell J       Date:  2013-05-05       Impact factor: 2.479

Review 9.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

Authors:  Jonathan D Cherry; John A Olschowka; M Kerry O'Banion
Journal:  J Neuroinflammation       Date:  2014-06-03       Impact factor: 8.322

10.  Differential detection of impact site versus rotational site injury by magnetic resonance imaging and microglial morphology in an unrestrained mild closed head injury model.

Authors:  Alfredo Hernandez; Virgina Donovan; Yelena Y Grinberg; Andre Obenaus; Monica J Carson
Journal:  J Neurochem       Date:  2016-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.